For the best experienceDownload the Mobile App
App Store Play Store
New pill nearly doubles survival time for pancreatic cancer patients
New pill nearly doubles survival time for pancreatic cancer patients
New pill nearly doubles survival time for pancreatic cancer patients

Published on: 05/31/2026

This news was posted by Oregon Today News

Go To Business Place

Description

Researchers say the pill, daraxonrasib, works by blocking a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases.

News Source : https://www.kgw.com/article/news/health/experimental-pill-pancreatic-cancer-treatment/507-3566d833-d519-4d66-aaeb-6c773551a7b0

Other Related News

Suspect wanted after road rage shooting near Pleasant Valley
Suspect wanted after road rage shooting near Pleasant Valley
Suspect wanted after road rage shooting near Pleasant Valley

05/31/2026

Deputies are searching for a suspect who shot at another person after being passed on the ...

Can you think of any exceptions to this rule? 🤔
Can you think of any exceptions to this rule? 🤔
Can you think of any exceptions to this rule? 🤔

05/31/2026

Can you think of any exceptions to this rule

Walmart e-bike deal: Electric mountain bike $300 off
Walmart e-bike deal: Electric mountain bike $300 off
Walmart e-bike deal: Electric mountain bike $300 off

05/31/2026

Summer is right around the corner which means theres still time to explore long dirt roads...

Is migration into Oregon cooling again? Driver’s license data suggests a slowdown
Is migration into Oregon cooling again? Driver’s license data suggests a slowdown
Is migration into Oregon cooling again? Driver’s license data suggests a slowdown

05/31/2026

When people move to a new part of the country one thing that binds them to their new home ...

Liz Weston: Financial analyst questions $50,000 capital gains move by new advisor
Liz Weston: Financial analyst questions $50,000 capital gains move by new advisor
Liz Weston: Financial analyst questions $50,000 capital gains move by new advisor

05/31/2026

Dear Readers The following comment was prompted by my response to the letter from a couple...

ShoutoutGive Shoutout
500/500